Most transcluded pages

Jump to: navigation, search

Showing below up to 39 results in range #1 to #39.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Template:TOC limit‏‎ (used on 233 pages)
  2. Template:Border-radius‏‎ (used on 158 pages)
  3. Allogeneic HSCT‏‎ (used on 16 pages)
  4. Autologous HSCT‏‎ (used on 11 pages)
  5. Section editor transclusions‏‎ (used on 5 pages)
  6. Autologous HSCT conditioning regimens‏‎ (used on 5 pages)
  7. Multiple myeloma‏‎ (used on 3 pages)
  8. Cisplatin & Gemcitabine for bladder cancer, neoadjuvant‏‎ (used on 2 pages)
  9. Nivolumab (Opdivo) for unresectable or metastatic bladder cancer‏‎ (used on 2 pages)
  10. Radiation therapy for anal cancer‏‎ (used on 2 pages)
  11. Fluorouracil, cisplatin, radiation therapy for anal cancer‏‎ (used on 2 pages)
  12. Fluorouracil, mitomycin, radiation therapy for anal cancer‏‎ (used on 2 pages)
  13. Fluorouracil & cisplatin for anal cancer‏‎ (used on 2 pages)
  14. Gemcitabine & Oxaliplatin for biliary tract cancer‏‎ (used on 2 pages)
  15. Granisetron‏‎ (used on 2 pages)
  16. Granisetron (Kytril)‏‎ (used on 2 pages)
  17. Avelumab (Bavencio) for merkel cell carcinoma‏‎ (used on 2 pages)
  18. Avelumab (Bavencio) for metastatic bladder cancer‏‎ (used on 2 pages)
  19. Ipilimumab (Yervoy) for melanoma, adjuvant‏‎ (used on 2 pages)
  20. Midostaurin (Rydapt) for aggressive systemic mastocytosis‏‎ (used on 2 pages)
  21. Brigatinib (Alunbrig) for advanced or metastatic ALK-positive non-small cell lung cancer‏‎ (used on 2 pages)
  22. Midostaurin (Rydapt) maintenance therapy for acute myeloid leukemia (AML)‏‎ (used on 2 pages)
  23. Carboplatin & gemcitabine for unresectable or metastatic bladder cancer‏‎ (used on 2 pages)
  24. Nivolumab (Opdivo) for melanoma, adjuvant‏‎ (used on 2 pages)
  25. Cytarabine, Daunorubicin, and Midostaurin induction therapy for acute myeloid leukemia (AML)‏‎ (used on 1 page)
  26. Pembrolizumab & Pemetrexed maintenance therapy for advanced or metastatic non-small cell lung cancer‏‎ (used on 1 page)
  27. Cytarabine & Midostaurin consolidation therapy for acute myeloid leukemia (AML)‏‎ (used on 1 page)
  28. Pembrolizumab (Keytruda) for unresectable or metastatic colon cancer‏‎ (used on 1 page)
  29. Durvalumab (Imfinzi) for metastatic bladder cancer‏‎ (used on 1 page)
  30. Regorafenib (Stivarga) for hepatocellular carcinoma‏‎ (used on 1 page)
  31. Thiotepa (Thioplex)‏‎ (used on 1 page)
  32. Atezolizumab (Tecentriq) for metastatic bladder cancer‏‎ (used on 1 page)
  33. User:PeterYang‏‎ (used on 1 page)
  34. HemOnc.org - A Hematology Oncology Wiki:Privacy policy‏‎ (used on 1 page)
  35. MediaWiki:Confirmemail body‏‎ (used on 1 page)
  36. HLH-2004 for untreated hemophagocytic lymphohistiocytosis (HLH)‏‎ (used on 1 page)
  37. MediaWiki:Sitenotice‏‎ (used on 1 page)
  38. Bacillus Calmette-Guerin (BCG) intravesicular chemotherapy in bladder cancer‏‎ (used on 1 page)
  39. Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer‏‎ (used on 1 page)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)